Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Jorge Alió, WOC 2018 – Updates in Refractive Surgery

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 26th 2018

Dr Jorge Alió (Professor and Chairman of Ophthalmology, University of Miguel Hernandez de Elche, Alicante, Spain) highlights the recent developments in refractive surgery and diagnostic equipment, including the SMILE and LASIK techniques. He also discusses the challenges involved in treating patients, particularly those with presbyopia, and managing patient expectations. Finally, he reviews the future developments in refractive surgery and his highlights from the WOC meeting.

Questions:
1. What have been the most significant recent developments in the area of refractive surgery? (0:23)
2. What challenges do you face when treating patients? (1:48)
3. What developments are you most excited about in the area of refractive surgery over the next few years? (4:01)
4. What have you found most interesting at this year’s WOC meeting? (6:09)

Filmed at the 2018 World Ophthalmology Congress (WOC) of the International Council of Ophthalmology (ICOPH), June 2018, Barcelona, Spain.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup